2018
Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement
Rivera MP, Tanner NT, Silvestri GA, Detterbeck FC, Tammemägi MC, Young RP, Slatore CG, Caverly TJ, Boyd CM, Braithwaite D, Fathi JT, Gould MK, Iaccarino JM, Malkoski SP, Mazzone PJ, Tanoue LT, Schoenborn NL, Zulueta JJ, Wiener RS. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. American Journal Of Respiratory And Critical Care Medicine 2018, 198: e3-e13. PMID: 30004250, DOI: 10.1164/rccm.201805-0986st.Peer-Reviewed Original ResearchConceptsLung cancer screeningRisk of deathPatient selectionChronic illnessCancer screeningLung cancerOfficial American Thoracic Society Research StatementHarms of LCSImplementation of LCSScreen-detected lung cancersChronic obstructive pulmonary diseaseRisk of comorbiditiesObstructive pulmonary diseaseEffect of comorbidityLung cancer deathsTreatment-related harmsLung cancer riskBalance of benefitsPulmonary diseaseCancer deathBaseline riskCancer riskComorbiditiesHealthy individualsInternational clinicians
2017
Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT
Gao SJ, Kim AW, Puchalski JT, Bramley K, Detterbeck FC, Boffa DJ, Decker RH. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT. Lung Cancer 2017, 109: 36-41. PMID: 28577947, DOI: 10.1016/j.lungcan.2017.04.018.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungClinical Decision-MakingDiagnostic ImagingFemaleHumansLung NeoplasmsMaleMediastinumMiddle AgedNeoplasm MetastasisNeoplasm StagingPatient SelectionPositron Emission Tomography Computed TomographyPractice Guidelines as TopicRetrospective StudiesConceptsOccult N2 diseaseOccult N2 metastasesGround-glass componentInvasive mediastinal stagingCurative-intent therapyT2 tumorsN2 metastasisPET-CTInvasive stagingN2 diseaseT1 tumorsNegative predictive valueMediastinal stagingEarly non-small cell lung cancerExact testPredictive valueSolid tumorsNon-small cell lung cancerClinical stage I NSCLCN2 lymph nodesNode-negative NSCLCOccult nodal involvementPure-solid tumorsStage I NSCLCT1-2N0 disease
2014
The International Thymic Malignancy Interest Group Thymic Initiative: A State-of-the-Art Study of Thymic Malignancies
Detterbeck F, Korst R. The International Thymic Malignancy Interest Group Thymic Initiative: A State-of-the-Art Study of Thymic Malignancies. Seminars In Thoracic And Cardiovascular Surgery 2014, 26: 317-322. PMID: 25837546, DOI: 10.1053/j.semtcvs.2015.02.002.Peer-Reviewed Original Research
2011
The Masaoka-Koga Stage Classification for Thymic Malignancies: Clarification and Definition of Terms
Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran C. The Masaoka-Koga Stage Classification for Thymic Malignancies: Clarification and Definition of Terms. Journal Of Thoracic Oncology 2011, 6: s1710-s1716. PMID: 21847052, DOI: 10.1097/jto.0b013e31821e8cff.Peer-Reviewed Original Research
2007
Beliefs among Physicians in the Diagnostic and Therapeutic Approach to Non-small Cell Lung Cancer
Stinchcombe TE, Detterbeck FC, Lin L, Rivera MP, Socinski MA. Beliefs among Physicians in the Diagnostic and Therapeutic Approach to Non-small Cell Lung Cancer. Journal Of Thoracic Oncology 2007, 2: 819-826. PMID: 17805059, DOI: 10.1097/jto.0b013e31811f478a.Peer-Reviewed Original ResearchMeSH KeywordsCarcinoma, Non-Small-Cell LungClinical CompetenceCombined Modality TherapyFemaleHumansLung NeoplasmsMaleNeoplasm StagingOutcome Assessment, Health CarePractice Guidelines as TopicQuality of LifeRetrospective StudiesSeverity of Illness IndexSurveys and QuestionnairesSurvival RateUnited StatesConceptsEvidence-based guidelinesStage IV diseaseSolitary pulmonary nodulesLung cancerPhysicians' beliefsPractice beliefsPulmonary nodulesNon-small cell lung cancerRole of chemotherapyStage III diseaseMediastinal lymph nodesPostoperative radiation therapyCell lung cancerTreatment of patientsMajority of physiciansQuality of lifePositron emission tomographyReminder e-mailsAdjuvant chemotherapyOperable patientsSurvival benefitChest PhysiciansLymph nodesPractice patternsRadiation therapy